Inspire Medical Systems, Inc.
INSP
$162.16
$3.322.09%
| Weiss Ratings | INSP - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C | |||
| Rating Factors | INSP - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Excellent | |||
| Efficiency Index | Fair | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | INSP - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.98 | |||
| Price History | INSP - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -7.39% | |||
| 30-Day Total Return | -16.20% | |||
| 60-Day Total Return | -14.12% | |||
| 90-Day Total Return | -14.97% | |||
| Year to Date Total Return | -14.29% | |||
| 1-Year Total Return | -15.87% | |||
| 2-Year Total Return | -33.01% | |||
| 3-Year Total Return | -21.82% | |||
| 5-Year Total Return | 214.81% | |||
| 52-Week High % Change | -37.00% | |||
| 52-Week Low % Change | 31.84% | |||
| Price | INSP - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $257.40 | |||
| 52-Week Low Price | $123.00 | |||
| 52-Week Low Price (Date) | Jul 26, 2024 | |||
| 52-Week High Price (Date) | May 03, 2024 | |||
| Valuation | INSP - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 4.81B | |||
| Enterprise Value | 4.40B | |||
| Price/Earnings (TTM) | 94.06 | |||
| Earnings Per Share (TTM) | 1.72 | |||
| Earnings Per Share Growth | -333.07% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 6.21 | |||
| Price/Book (Q) | 6.99 | |||
| Enterprise Value/Revenue (TTM) | 5.48 | |||
| Price | $162.16 | |||
| Enterprise Value/EBITDA (TTM) | 103.15 | |||
| Enterprise Value/EBIT | 121.87 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | INSP - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 30.75M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | INSP - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (844) 672-4357 | |||
| Address | 5500 Wayzata Blvd. Golden Valley, MN 55416 | |||
| Website | www.inspiresleep.com | |||
| Country | United States | |||
| Year Founded | 2007 | |||
| Profitability | INSP - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 4.49% | |||
| Profit Margin | 6.66% | |||
| Management Effectiveness | INSP - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 3.04% | |||
| Return on Equity | 8.48% | |||
| Income Statement | INSP - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 802.80M | |||
| Total Revenue (TTM) | 802.80M | |||
| Revenue Per Share | $26.11 | |||
| Gross Profit (TTM) | 679.82M | |||
| EBITDA (TTM) | 42.63M | |||
| EBIT (TTM) | 36.08M | |||
| Net Income (TTM) | 53.51M | |||
| Net Income Avl. to Common (TTM) | 53.51M | |||
| Total Revenue Growth (Q YOY) | 24.52% | |||
| Earnings Growth (Q YOY) | 138.60% | |||
| EPS Diluted (TTM) | 1.72 | |||
| EPS Diluted Growth (Q YOY) | 132.40% | |||
| Balance Sheet | INSP - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 445.55M | |||
| Cash Per Share (Q) | $14.49 | |||
| Total Current Assets (Q) | 630.81M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 689.70M | |||
| Current Ratio (Q) | 7.128 | |||
| Book Value Per Share (Q) | $23.19 | |||
| Total Assets (Q) | 808.38M | |||
| Total Current Liabilities (Q) | 88.50M | |||
| Total Debt (Q) | 31.79M | |||
| Total Liabilities (Q) | 118.69M | |||
| Total Common Equity (Q) | 689.70M | |||
| Cash Flow | INSP - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -113.12M | |||
| Cash from Financing (TTM) | -52.39M | |||
| Net Change in Cash (TTM) | -35.39M | |||
| Levered Free Cash Flow (TTM) | 2.27M | |||
| Cash from Operations (TTM) | 130.25M | |||
